High-Dimensional Analysis of Single-Cell Flow Cytometry Data Predicts Relapse in Childhood Acute Lymphoblastic Leukaemia.
Salvador ChuliánÁlvaro MartínezVictor M Pérez-GarcíaMaría RosaCristina Blázquez GoñiJuan Francisco Rodríguez GutiérrezLourdes Hermosín-RamosÁgueda Molinos QuintanaTeresa Caballero-VelázquezManuel RamírezAna Castillo RobledaJuan Luis Fernández-MartínezPublished in: Cancers (2020)
Artificial intelligence methods may help in unveiling information that is hidden in high-dimensional oncological data. Flow cytometry studies of haematological malignancies provide quantitative data with the potential to be used for the construction of response biomarkers. Many computational methods from the bioinformatics toolbox can be applied to these data, but they have not been exploited in their full potential in leukaemias, specifically for the case of childhood B-cell Acute Lymphoblastic Leukaemia. In this paper, we analysed flow cytometry data that were obtained at diagnosis from 56 paediatric B-cell Acute Lymphoblastic Leukaemia patients from two local institutions. Our aim was to assess the prognostic potential of immunophenotypical marker expression intensity. We constructed classifiers that are based on the Fisher's Ratio to quantify differences between patients with relapsing and non-relapsing disease. We also correlated this with genetic information. The main result that arises from the data was the association between subexpression of marker CD38 and the probability of relapse.
Keyphrases
- flow cytometry
- big data
- artificial intelligence
- electronic health record
- liver failure
- multiple sclerosis
- single cell
- machine learning
- respiratory failure
- intensive care unit
- end stage renal disease
- gene expression
- ejection fraction
- healthcare
- data analysis
- risk assessment
- young adults
- drug induced
- minimally invasive
- hepatitis b virus
- social media
- genome wide
- climate change
- copy number
- health information
- mass spectrometry
- prognostic factors
- rna seq